Home / Denmark / Novozymes A/S
Novozymes A/S
Short position disclosed on March 31, 2026.
1.00% of the capital sold short
1 disclosing funds
222 disclosures on record
DK0060336014 ISIN code
Funds holding Novozymes A/S Titelia
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Oct 2025Jan 2026Apr 2026Jul 2026
November 1, 2012 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| AQR Capital Management, LLC | 1.00% | new | March 31, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 31, 2026 | AQR Capital Management, LLC | 1.00% | still open |
| February 18, 2026 | AQR Capital Management, LLC | 0.90% | February 18, 2026 |
| January 5, 2026 | AQR Capital Management, LLC | 0.80% | January 5, 2026 |
| December 1, 2025 | AQR Capital Management, LLC | 0.70% | December 1, 2025 |
| October 29, 2025 | AQR Capital Management, LLC | 0.60% | October 29, 2025 |
| August 19, 2025 | AQR Capital Management, LLC | 0.50% | August 19, 2025 |
| April 30, 2025 | AQR Capital Management, LLC | 0.49% | April 30, 2025 |
| March 12, 2025 | AQR Capital Management, LLC | 0.50% | March 12, 2025 |
| February 2, 2024 | UBS O'Connor LLC | 0.00% | February 2, 2024 |
| January 31, 2024 | UBS O'Connor LLC | 1.15% | January 31, 2024 |
| January 31, 2024 | AQR Capital Management, LLC | 0.43% | January 31, 2024 |
| January 31, 2024 | D. E. Shaw & Co. (London), LLP | 0.00% | January 31, 2024 |
| January 31, 2024 | Farallon Capital Management, L.L.C. | 0.00% | January 31, 2024 |
| January 31, 2024 | Mirabella Financial Services LLP | 0.00% | January 31, 2024 |
| January 31, 2024 | Syquant Capital | 0.00% | January 31, 2024 |
| January 30, 2024 | Davidson Kempner European Partners, LLP | 0.00% | January 30, 2024 |
| January 29, 2024 | Mirabella Financial Services LLP | 0.60% | January 29, 2024 |
| January 26, 2024 | Syquant Capital | 0.61% | January 26, 2024 |
| January 22, 2024 | Syquant Capital | 0.51% | January 22, 2024 |
| January 19, 2024 | UBS O'Connor LLC | 1.91% | January 19, 2024 |
| January 19, 2024 | AQR Capital Management, LLC | 0.70% | January 19, 2024 |
| January 17, 2024 | Magnetar Financial LLC | 0.41% | January 17, 2024 |
| January 15, 2024 | UBS O'Connor LLC | 1.84% | January 15, 2024 |
| January 11, 2024 | UBS O'Connor LLC | 1.71% | January 11, 2024 |
| January 10, 2024 | Davidson Kempner European Partners, LLP | 6.39% | January 10, 2024 |
| January 4, 2024 | UBS O'Connor LLC | 1.61% | January 4, 2024 |
| January 4, 2024 | AQR Capital Management, LLC | 0.69% | January 4, 2024 |
| December 13, 2023 | Davidson Kempner European Partners, LLP | 6.44% | December 13, 2023 |
| December 7, 2023 | UBS O'Connor LLC | 1.51% | December 7, 2023 |
| December 6, 2023 | Davidson Kempner European Partners, LLP | 6.58% | December 6, 2023 |
| December 1, 2023 | UBS O'Connor LLC | 1.45% | December 1, 2023 |
| November 30, 2023 | Davidson Kempner European Partners, LLP | 6.62% | November 30, 2023 |
| November 29, 2023 | Davidson Kempner European Partners, LLP | 6.70% | November 29, 2023 |
| November 27, 2023 | UBS O'Connor LLC | 1.51% | November 27, 2023 |
| November 16, 2023 | Davidson Kempner European Partners, LLP | 6.62% | November 16, 2023 |
| November 13, 2023 | Davidson Kempner European Partners, LLP | 6.51% | November 13, 2023 |
| November 13, 2023 | UBS O'Connor LLC | 1.40% | November 13, 2023 |
| November 10, 2023 | Mirabella Financial Services LLP | 0.51% | November 10, 2023 |
| November 1, 2023 | Davidson Kempner European Partners, LLP | 6.40% | November 1, 2023 |
| October 31, 2023 | UBS O'Connor LLC | 1.31% | October 31, 2023 |
| October 27, 2023 | Davidson Kempner European Partners, LLP | 6.31% | October 27, 2023 |
| October 26, 2023 | Davidson Kempner European Partners, LLP | 6.27% | October 26, 2023 |
| October 24, 2023 | Davidson Kempner European Partners, LLP | 6.10% | October 24, 2023 |
| October 23, 2023 | Davidson Kempner European Partners, LLP | 6.07% | October 23, 2023 |
| October 20, 2023 | UBS O'Connor LLC | 1.21% | October 20, 2023 |
| October 19, 2023 | Davidson Kempner European Partners, LLP | 5.97% | October 19, 2023 |
| October 16, 2023 | UBS O'Connor LLC | 1.11% | October 16, 2023 |
| October 11, 2023 | Magnetar Financial LLC | 0.62% | October 11, 2023 |
| October 10, 2023 | Davidson Kempner European Partners, LLP | 5.70% | October 10, 2023 |
| October 9, 2023 | Davidson Kempner European Partners, LLP | 5.53% | October 9, 2023 |
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
- Coloplast A/S 0.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Novozymes A/S, source Finanstilsynet, data as at March 31, 2026, https://www.quivad.com/action/novozymes-a-s